| abstract |
Compounds of the following 1,3-propane diol linked structure, when for use in therapy: where R1 is an acyl or fatty alcohol group derived from a C12-30 preferably C16-30 fatty acid desirably with two or more cis or trans double bonds, and R2 is hydrogen, or an acyl or fatty alcohol group as R1 the same or different, or any other nutrient, drug or other bioactive residue. |